Nektar Therapeutics Highlights Presentation Of Preliminary Immune Activation, Safety And Clinical Activity Data From The Ongoing Dose-Escalation Stage Of REVEAL Study At 2019 ASCO-SITC Meeting
Benzinga Newsdesk